LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Home・Akcijų sąrašas・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

21.36 -0.09

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

21.27

Max

21.39

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-1.6M -21M
Pardavimai	14M 54M
Pelno marža	-39.611
Darbuotojai	178
EBITDA	-3.8M -23M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	-2.11% downside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	1B 2.2B
Ankstesnė atidarymo kaina	21.45
Ankstesnė uždarymo kaina	21.36

Naujienos nuotaikos

By Acuity

50%

165 / 350 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

6.26 / 7.47 Palaikymas ir pasipriešinimas

Day One Biopharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-20 17:19; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

2026-03-20 16:45; UTC

Svarbiausios naujienos

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

2026-03-20 16:22; UTC

Svarbiausios naujienos

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

2026-03-20 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 20:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 19:55; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Brent Crude Closes Out Volatile Week Higher -- Market Talk

2026-03-20 19:28; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

2026-03-20 19:28; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 18:39; UTC

Rinkos pokalbiai

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

2026-03-20 18:31; UTC

Įsigijimai, susijungimai, perėmimai

Honeywell Announces Pricing of Debt Tender Offers >HON

2026-03-20 18:19; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- Update

2026-03-20 18:15; UTC

Rinkos pokalbiai

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

2026-03-20 17:57; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Inches Up -- Market Talk

2026-03-20 17:04; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

2026-03-20 16:20; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 16:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 15:40; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

2026-03-20 15:30; UTC

Uždarbis

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

2026-03-20 15:26; UTC

Rinkos pokalbiai

Uždarbis

Svarbiausios naujienos

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

2026-03-20 15:26; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

2026-03-20 15:25; UTC

Rinkos pokalbiai

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

2026-03-20 15:19; UTC

Rinkos pokalbiai

Svarbiausios naujienos

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

2026-03-20 14:58; UTC

Svarbiausios naujienos

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

2026-03-20 14:55; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Lower as Speculative Pullback Extends -- Market Talk

2026-03-20 14:54; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 14:53; UTC

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

2026-03-20 14:46; UTC

Rinkos pokalbiai

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

2026-03-20 14:45; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Akcijų palyginimas

Kainos pokytis

Day One Biopharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

-2.11% į apačią

12 mėnesių prognozė

Vidutinis 20.86 USD -2.11%

Aukščiausias 21.5 USD

Žemiausias 17 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Day One Biopharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

9 ratings

Pirkti

Laikyti

Parduoti

Remiantis 9 analitikų, pateikusių Day One Biopharmaceuticals Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

6.26 / 7.47Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Rinkos nuotaikos

By Acuity

165 / 350 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.